| 英文名称 |
中文名称 |
CAS号 |
操作 |
| HA130 |
HA 130,自分泌运动抑制剂 |
1229652-21-4 |
详细
|
| IDO5L；INCB14943;INCB024360 analogue |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914471-09-3 |
详细
|
| MK-8245；MK8245;MK 8245 |
MK-8245 |
1030612-90-8 |
详细
|
| Menin-MLL inhibitor MI-2；MI-2;Menin-MLL inhibitor 2;Menin-MLL Inhibitor;MI 2;MI2 |
MI-2 (Menin-MLL Inhibitor) |
1271738-62-5 |
详细
|
| Pimecrolimus；SDZ-ASM 981;ASM 981 |
吡美莫司 |
137071-32-0 |
详细
|
| IWR-1；IWR-1-endo;endo-IWR 1 |
IWR-1 |
1127442-82-3 |
详细
|
| TGX-221；TGX221;TGX 221 |
(+/-)-7-甲基-2-(吗啉-4-基)-9-(1-苯基氨基乙基)吡啶并[1,2-A]嘧啶-4-酮 |
663619-89-4 |
详细
|
| IC-87114；IC87114;IC 87114 |
2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 |
371242-69-2 |
详细
|
| Fruquintinib；HMPL-013 |
呋喹替尼 |
1194506-26-7 |
详细
|
| GSK2656157 |
GSK2656157 |
1337532-29-2 |
详细
|
| CEP-37440；CEP37440 |
CEP-37440 |
1391712-60-9 |
详细
|
| GW2580；GW 2580;SC-203877 |
GW2580 |
870483-87-7 |
详细
|
| Alda-1；Alda 1 |
N-(1,3-苯并二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺 |
349438-38-6 |
详细
|
| Elacridar；GW0918;GG918;GF120918;GW120918 |
依克立达 |
143664-11-3 |
详细
|
| GTS-21 dihydrochloride；GTS 21 dihydrochloride;DMBX-anabaseine;DMXB-A |
(3E)-3-[(2,4-二甲氧基苯基)亚甲基]-3,4,5,6-四氢-2,3'-联吡啶二盐酸盐 |
156223-05-1 |
详细
|
| Taladegib；LY2940680 |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 |
1258861-20-9 |
详细
|
| Crenolanib；CP-868596;ARO 002 |
[1-[2-[5-(3-甲基氧杂环丁烷-3-基甲氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基]胺 |
670220-88-9 |
详细
|
| Regadenoson；Lexiscan;CVT-3146 |
瑞加德松 |
313348-27-5 |
详细
|
| GSK0660 |
GSK0660 |
1014691-61-2 |
详细
|
| LB42708 |
2MG |
226929-39-1 |
详细
|
| BMS-265246；BMS265246;BMS 265246 |
BMS265246 |
582315-72-8 |
详细
|
| PIK-75；PIK75 |
2-甲基-5-硝基-1-苯磺酰[2-[(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]-1-甲基肼] |
372196-67-3 |
详细
|
| PF-04217903；PF 04217903;PF04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
详细
|
| ML167；NCGC00188654;CID44968231 |
5-[4-[[(5-甲基-2-呋喃基)甲基]氨基]-6-喹唑啉基]-2-呋喃甲醇 |
1285702-20-6 |
详细
|
| TG100-115 |
3,3'-(2,4-二氨基-6,7-蝶啶二基)二苯酚 |
677297-51-7 |
详细
|
| Timapiprant；OC000459 |
[5-氟-2-甲基-3-(喹啉-2-基甲基)吲哚-1-基]乙酸 |
851723-84-7 |
详细
|
| JNK-IN-8；JNK Inhibitor XVI |
JNK-IN-8 |
1410880-22-6 |
详细
|
| 4EGI-1；4EGI1;4EGI 1 |
4EGI-1 |
315706-13-9 |
详细
|
| Bentamapimod；AS 602801 |
本塔马莫 |
848344-36-5 |
详细
|
| A 438079 hydrochloride；A-438079 hydrochloride;A-438079 HCl;A 438079 (hydrochloride) |
A 438079 (hydrochloride) |
899431-18-6 |
详细
|
| Barasertib-HQPA；Barasertib;AZD1152-HQPA;1H-Pyrazole-3-acetamide;AZD2811;AZD1152-HQPA|AZD2811 |
5-[[7-[3-[乙基(2-羟基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺 |
722544-51-6 |
详细
|
| Spebrutinib；AVL-292;LMK-435;CC-292 |
AVL292 |
1202757-89-8 |
详细
|
| A40926；Dalbavancin Impurity |
达巴霉素杂质 |
102961-72-8 |
详细
|
| Tranilast；MK 341;SB 252218 |
曲尼司特 |
53902-12-8 |
详细
|
| LY310762；LY310762 HCl |
LY310762 |
192927-92-7 |
详细
|
| Eflornithine hydrochloride hydrate；Difluoromethylornithine hydrochloride hydrate;RMI-71782 hydrochloride hydrate;DFMO hydrochloride hydrate;Eflornithine hydrochloride Monohydrate;Eflornithine hydrochloride;α-difluoromethylornithine hydrochloride hydrate;MDL-71782 hydrochloride hydrate |
依氟鸟氨酸盐酸盐一水合物 |
96020-91-6 |
详细
|
| Veliparib；ABT-888;NSC 737664 |
维利帕尼 |
912444-00-9 |
详细
|
| hPGDS-IN-1 |
化合物HPGDS-IN-1 |
1234708-04-3 |
详细
|
| Norgestrel；SH-850;WY-3707;SH-70850;FH 122-A |
炔诺孕酮 |
6533-00-2 |
详细
|
| Lumacaftor；VX-809;VRT 826809 |
鲁玛卡托 |
936727-05-8 |
详细
|
| Fostamatinib Disodium；R788 Disodium;R788(Disodium);Tamatinib Fosdium;R788 (Fostamatinib) Disodium |
R788(FOSTAMATINIB DISODIUM) |
1025687-58-4 |
详细
|
| Dextromilnacipran；Levomilnacipran |
左旋体米那普仑 |
96847-55-1 |
详细
|
| AG490；Tyrphostin AG 490;Zinc02557947;AG-490;Tyrphostin B42;AG 490 |
酪氨酸磷酸化抑制剂AG 490 |
133550-30-8 |
详细
|
| Omeprazole sulfide；Omeprazole metabolite Omeprazole sulfide;Ufiprazole |
奥美拉唑硫醚 |
73590-85-9 |
详细
|
| Vismodegib；Erivedge;RG 3616;GDC-0449 |
维莫德吉 |
879085-55-9 |
详细
|
| AZ3146；AZ 3146 |
AZ3146 |
1124329-14-1 |
详细
|
| Oritavancin diphosphate；LY333328 diphosphate |
奥利万星二磷酸盐 |
192564-14-0 |
详细
|
| NVP-BVU972 |
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]哒嗪-3-基]甲基]喹啉 |
1185763-69-2 |
详细
|
| Ropinirole hydrochloride；SKF 101468 hydrochloride;Ropinirole HCl;SKF-101468A |
盐酸罗匹尼罗 |
91374-20-8 |
详细
|
| AG1024；Tyrphostin AG 1024;AGS 200;Tyrphostin |
AG1024 |
65678-07-1 |
详细
|
| Esomeprazole Sodium；(S)-Omeprazole sodium |
埃索美拉唑钠 |
161796-78-7 |
详细
|
| 1-Ethyl-2-benzimidazolinone；1-EBIO |
氯唑沙宗类似物 |
10045-45-1 |
详细
|
| Vidofludimus；4sc-101;SC12267 |
维多氟拉迪莫 |
717824-30-1 |
详细
|
| Dolasetron Mesylate hydrate；Dalasetron Mesylate Hydrate |
甲磺酸多拉司琼 |
878143-33-0 |
详细
|
| Thymopentin；TP5 |
胸腺五肽 |
69558-55-0 |
详细
|
| Esomeprazole Magnesium；NEXIUM;(-)-Omeprazole magnesium;(S)-Omeprazole magnesium |
埃索美拉唑镁 |
161973-10-0 |
详细
|
| KN-62；KN 62;KN62 |
1-[N,O-二(5-异喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪 |
127191-97-3 |
详细
|
| KU-55933；ATM Kinase Inhibitor;KU55933 |
2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 |
587871-26-9 |
详细
|
| Pirenperone |
哌南氟酮 |
75444-65-4 |
详细
|
| JNJ-1661010；JNJ 1661010;Takeda-25;JNJ1661010 |
JNJ 1661010 |
681136-29-8 |
详细
|
| IWP L6；Porcn?Inhibitor?III;IWP-L6;Porcn Inhibitor III |
IWP-L6 |
1427782-89-5 |
详细
|
| Acalisib；CAL-120;GS-9820 |
GS-9820 |
870281-34-8 |
详细
|
| MK-0752；MK0752 |
顺式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)环己烷丙酸 |
471905-41-6 |
详细
|
| CH5132799 |
CH5132799 |
1007207-67-1 |
详细
|
| RI-2；RI 2;RI2 |
化合物RI-2 |
1417162-36-7 |
详细
|
| BMS-599626；AC480;BMS 599626 |
AC480 (BMS-599626) |
714971-09-2 |
详细
|
| GSK429286A；RHO-15 |
N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺 |
864082-47-3 |
详细
|
| LY2811376 |
(4S)-4-[2,4-二氟-5-(5-嘧啶基)苯基]-5,6-二氢-4-甲基-4H-1,3-噻嗪-2-胺 |
1194044-20-6 |
详细
|
| WAY-100635 Maleate |
WAY100635 |
1092679-51-0 |
详细
|
| KRCA-0008；KRCA 0008;KRCA0008 |
1,1'-((((5-氯嘧啶-2,4-二基)双(氮烷二基))双(3-甲氧基-4,1-亚苯基))双(哌嗪-4,1-二基))双(乙-1-酮) |
1472795-20-2 |
详细
|
| Nolatrexed dihydrochloride；Thymitaq;AG 337 |
盐酸诺拉曲塞 |
152946-68-4 |
详细
|
| Flavopiridol hydrochloride；HL 275;Alvocidib Hydrochloride;FLAVOPIRIDOL HCL;NSC 649890 HCl;MDL 107826A;NSC 649890 |
(-)-2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]-4H-1-苯并吡喃-4-酮盐酸盐 |
131740-09-5 |
详细
|
| Rostafuroxin；PST 2238 |
ROSTAFUROXIN |
156722-18-8 |
详细
|
| PIK-93；PIK 93;PIK93 |
N-[5-[4-氯-3-[[(2-羟基乙基)氨基]磺酰基]苯基]-4-甲基-2-噻唑基]乙酰胺 |
593960-11-3 |
详细
|
| Poziotinib；HM781-36B;NOV120101 |
波齐替尼 |
1092364-38-9 |
详细
|
| CHIR-98014；CHIR98014;CHIR 98014;CT98014 |
CHIR98014(CT98014) |
252935-94-7 |
详细
|
| PD98059；PD 98059 |
2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮 |
167869-21-8 |
详细
|
| Masitinib；AB1010 |
马赛替尼（Masitinib） |
790299-79-5 |
详细
|
| Org 27569 |
ORG275695-氯-3-乙基-N-[2-[4-(1-哌啶基)苯基]乙基-1H-吲哚-2-甲酰胺 |
868273-06-7 |
详细
|
| SNS-314 Mesylate；SNS-314 |
N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸盐 (1:1) |
1146618-41-8 |
详细
|
| CEP-28122；CEP 28122;CEP28122 |
5MG |
1022958-60-6 |
详细
|
| Decernotinib；VRT-831509;VX-509 |
迪西替尼 |
944842-54-0 |
详细
|
| OSI-930；OSI 930 |
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺 |
728033-96-3 |
详细
|
| Gandotinib；LY2784544 |
LY 2784544 |
1229236-86-5 |
详细
|
| GSK 650394；GSK650394 |
2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
详细
|
| Rebastinib；DCC-2036;DCC2036;DCC 2036 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 |
1020172-07-9 |
详细
|
| UNC2881 |
UNC2881 |
1493764-08-1 |
详细
|
| Almorexant；ACT 078573 |
阿莫伦特 |
871224-64-5 |
详细
|
| (E)-Daporinad；APO866;(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE;Daporinad;FK866 |
(2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺 |
658084-64-1 |
详细
|
| GSK2606414 |
GSK2606414 |
1337531-36-8 |
详细
|
| G-749；G749;G 749 |
G-749 |
1457983-28-6 |
详细
|
| SBC-115076；SBC115076;SBC 115076 |
sbc-115076 |
489415-96-5 |
详细
|
| CCT 137690；CCT137690 |
甲磺酸阿贝西尼 |
1095382-05-0 |
详细
|
| LGK974；LGK 974;WNT974;LGK-974;NVP-LGK974 |
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺 |
1243244-14-5 |
详细
|
| A-1210477；A 1210477;A1210477 |
无中文名称 |
1668553-26-1 |
详细
|
| ADH-1；Exherin |
N-钙粘蛋白拮抗剂 |
229971-81-7 |
详细
|
| MSDC 0160；MSDC0160;CAY10415;Mitoglitazone;MSDC-0160 |
MSDC-0160 |
146062-49-9 |
详细
|
| Ro3280；RO 3280;Ro5203280 |
RO3280 |
1062243-51-9 |
详细
|
| PD173074 |
PD173074 |
219580-11-7 |
详细
|